Vogelgrippe - Durchbruch für SYNB - HEUTE Asien & morgen EUROPA! - 500 Beiträge pro Seite

[Inkmarker]

Schaut Euch mal die kleine Biotechfirma Synbiotics (SYNB) an!!!

Jetzt könnte es endlich zum Durchbruch für die Gesellschaft und Ihre Aktionäre kommen!!!

COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:

ASIAN GOVERNMENTS TEST SYNBIOTICS` FLU DETECT TEST STRIP

Feb 22, 2006 (AsiaPulse via COMTEX) -- (Full text of a statement. Contact details follow below.)
SAN DIEGO, Calif.--(BUSINESS WIRE)--Feb. 22, 2006--Evaluations by national animal health agencies in Thailand and Vietnam found Synbiotics Corp.`s Flu DETECT(TM) antigen test kit to be fast-acting and highly sensitive in testing for the H5N1 subtype of Avian Influenza Type A virus that has spread through poultry flocks and wild birds in Asia. Government and independent laboratories in Australia, Indonesia, Thailand, Vietnam and the United States also are conducting ongoing evaluations of the test, Synbiotics announced.

Flu DETECT, launched in spring 2005 at VIV Asia in Bangkok, detects all 16 sub-types of Avian Influenza Type A and can be used in the laboratory or on the farm. The fast-acting and sensitive Flu DETECT technology helps farmers, veterinarians and government health officials implement proper control measures, manage disease and ultimately reduce the economic loss associated with H5N1. This disease is highly pathogenic and causes severe disease and death in poultry. In rare cases, it has been transmitted from birds to humans.

The National Institute of Animal Health in Thailand reported that Flu DETECT is "easy to use" and provides quick results. A test by the Department of Animal Health in Vietnam noted Flu DETECT`s "high specificity" to the H5N1 subtype of Avian Influenza Type A and its sensitivity in samples with an extremely small amount of the virus.

Synbiotics` research shows this test may be 10 to 1,000 times more sensitive than other commonly used antigen test kits. In addition, it can detect all subtypes of Avian Influenza Virus Type A particles with a low virus load and provides results in just 15 minutes. The Flu DETECT kit is economical and easy to use in the laboratory or on the farm.

"The primary means of controlling Avian Influenza is through active surveillance, rapid detection and elimination of infected flocks," said Paul Hays, Synbiotics` chief executive officer. "Flu DETECT is the reliable and economic way for poultry producers and governments to quickly identify and combat this economically devastating disease."

Synbiotics is marketing Flu DETECT in Asia, the Middle East, Oceania, Latin America and Europe. The company has received conditional approval from the U.S. Department of Agriculture to market the product in the United States.

In addition to FLU DETECT, Synbiotics offers ProFLOK(R) AIV +, a USDA-approved laboratory test that detects the presence of Avian Influenza Type A virus antibodies in serum. ProFLOK AIV + ELISA methodology has been endorsed in the United States by the National Poultry Improvement Plan, a cooperative program of federal and state governments and the U.S. poultry industry to improve poultry and poultry products through the use of new technology.

Synbiotics Corp. develops, manufactures and markets veterinary diagnostics, instrumentation and related products for the companion animal, large animal and poultry markets worldwide. Headquartered in San Diego, Calif., Synbiotics manufactures and distributes its products through its operations in San Diego and Lyon, France. For information on Synbiotics and its products, visit the company`s website at www.synbiotics.com. To view this entire news release on Business Wire`s website, please go to www.businesswire.com.

CONTACT: For Synbiotics Corp.:

Nicholson Kovac, Inc.

Jenell Loschke, 816-460-3086

jloschkenicholsonkovac.com




(C) 2006 Asia Pulse Pte Ltd

-0-

INDUSTRY KEYWORD: Health/Pharmaceuticals
Technology
Livestock

[Inkmarker]

Kurzer Überblick über die Gesellschaft:

SYNB -- Synbiotics Corp.
Com (No Par)(New)

Search for Dun & Bradstreet reports on this company.

Address:
11011 Via Frontera
San Diego, CA 92127-1702
USA


Website: http://www.synbiotics.com
Phone: [phone]


Business Description: Not Available

State of Incorporation: CA


Officers:
Paul R. Hays, Pres. & COO: Keith A. Butler, CFO

Outstanding Shares: 33,822,067 as of 2005-11-17

Estimated Market Cap: Not Available


Current Capital Change:
shs decreased by 1 for 2000 split immediately followed by 2000 for 1 split. Payable upon surrender
Ex-Date: 2005-11-17
Record Date:
Pay Date:

Dividends:

Class Notes:
New Issue=8-83 400,000 shs at $10 by San Diego Securities, Inc
Capital Change=2-86 shs increased 2 for 1 split
Latest Addt`l Issue=6-87 1,500,000 shs at $8.50 by Prudental-Bache Capital Funding et al.


Transfer Agent:
Mellon Investor Services, Los Angeles, CA 90071

[turbozertifikat]

[posting]20.708.681 von Inkmarker am 15.03.06 20:43:39[/posting]Da wird ja nichts gehandelt, lächerliche 490 Stück bei den Amis.

[Inkmarker]

#3

Heute wurden immerhin mal wieder 43k gehandelt.

Indikatoren bei pk.com: $ 0,111 zu $ 0,125!